Minimal Residual Disease Market By Product Type (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), By Technology (Hematological Malignancy and Solid Tumors), By End-user (Hospitals & Specialty Clinics, Academic & Research Institutes, Diagnostic Laboratories, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034